• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为治疗勃起功能障碍的前列腺素E1的最低有效剂量。

The lowest effective dose of prostaglandin E1 as treatment for erectile dysfunction.

作者信息

Chen J, Godschalk M, Katz P G, Mulligan T

机构信息

Division of Urology, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia.

出版信息

J Urol. 1995 Jan;153(1):80-1. doi: 10.1097/00005392-199501000-00028.

DOI:10.1097/00005392-199501000-00028
PMID:7966797
Abstract

The recommended dose of prostaglandin E1 as treatment for erectile dysfunction has been reported to be 10 to 40 micrograms. However, adverse effects probably increase with increasing doses. We conducted a prospective, single-blind, dose-escalating study of prostaglandin E1 on 20 men with erectile dysfunction of various etiologies. The response to prostaglandin E1 was assessed by penile palpation and RigiScan rigidity monitoring. A total of 17 patients completed the study: 1 achieved rigidity with 1 microgram., 2 with 2 micrograms. and 4 with 3 micrograms. prostaglandin E1, while more than 70% achieved rigidity with 5 micrograms. or less and more than 80% had a full erection with 20 micrograms. Of 138 injections there were 2 episodes of pain after injection. We conclude that the often recommended starting dose of 20 micrograms. is too high. A more appropriate starting dose is 2.5 micrograms. with increments of 2.5 micrograms. until the lowest effective dose is achieved. This approach may lessen the major impediments to prostaglandin E1 use, that is burning and pain.

摘要

据报道,用于治疗勃起功能障碍的前列腺素E1推荐剂量为10至40微克。然而,不良反应可能会随着剂量增加而增多。我们对20名患有各种病因勃起功能障碍的男性进行了一项关于前列腺素E1的前瞻性、单盲、剂量递增研究。通过阴茎触诊和RigiScan硬度监测来评估对前列腺素E1的反应。共有17名患者完成了研究:1名患者使用1微克前列腺素E1达到了硬度,2名使用2微克,4名使用3微克。而超过70%的患者使用5微克或更低剂量达到了硬度,超过80%的患者使用20微克时有完全勃起。在138次注射中,有2次注射后出现疼痛。我们得出结论,通常推荐的20微克起始剂量过高。更合适的起始剂量是2.5微克,每次增加2.5微克,直至达到最低有效剂量。这种方法可能会减少使用前列腺素E1的主要障碍,即烧灼感和疼痛。

相似文献

1
The lowest effective dose of prostaglandin E1 as treatment for erectile dysfunction.作为治疗勃起功能障碍的前列腺素E1的最低有效剂量。
J Urol. 1995 Jan;153(1):80-1. doi: 10.1097/00005392-199501000-00028.
2
Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.患有不同潜在病因勃起功能障碍男性的阴茎海绵体内前列腺素Pge 1剂量与平均勃起持续时间的关系。
Croat Med J. 2007 Feb;48(1):76-80.
3
Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.勃起功能障碍男性阴茎海绵体内注射前列腺素E1后获得满意硬度的决定因素。
Int J Impot Res. 1996 Mar;8(1):9-16.
4
Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.脊髓损伤所致勃起功能障碍患者海绵体内注射前列腺素E1:初步报告
Paraplegia. 1995 Dec;33(12):731-3. doi: 10.1038/sc.1995.153.
5
[Initial experiences with prostaglandin E1 and PGE1 prepared injections].[前列腺素E1及注射用前列腺素E1的初步经验]
Helv Chir Acta. 1991 Sep;58(3):335-7.
6
[Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
Hinyokika Kiyo. 1993 Mar;39(3):289-92.
7
[Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].[阴茎海绵体内自体注射前列腺素E1用于勃起功能障碍的诊断与治疗]
Harefuah. 1994 Apr 1;126(7):369-73, 426.
8
[Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities].[前列腺素E1注射治疗勃起功能障碍。当前的诊断和治疗可能性]
Fortschr Med. 1990 Oct 20;108(30):577-80.
9
[Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].[经海绵体内注射前列腺素E1治疗性功能障碍。180例患者的报告]
Prog Urol. 1993 Dec;3(6):971-8.
10
A prostaglandin E1 dose-response study in man.人体中前列腺素E1的剂量反应研究。
J Urol. 1993 Dec;150(6):1825-8. doi: 10.1016/s0022-5347(17)35906-2.

引用本文的文献

1
Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.海绵体内注射前列地尔。其药效学、药代动力学特性及在勃起功能障碍中的治疗潜力综述。
Drugs Aging. 1996 Jan;8(1):56-74. doi: 10.2165/00002512-199608010-00009.